|
1
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schlachterman A, Craft WW Jr, Hilgenfeldt
E, Mitra A and Cabrera R: Current and future treatments for
hepatocellular carcinoma. World J Gastroenterol. 21:8478–8491.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng AL, Thongprasert S, Lim HY,
Sukeepaisarnjaroen W, Yang TS, Wu CC, Chao Y, Chan SL, Kudo M,
Ikeda M, et al: Randomized, open-label phase 2 study comparing
frontline dovitinib versus sorafenib in patients with advanced
hepatocellular carcinoma. Hepatology. 64:774–784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z,
Chen EB, Fan J, Cao Y, Dai Z and Zhou J: Tumor-associated
neutrophils recruit macrophages and T-regulatory cells to promote
progression of hepatocellular carcinoma and resistance to
sorafenib. Gastroenterology. 150:1646–1658.e17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye LY, Chen W, Bai XL, Xu XY, Zhang Q, Xia
XF, Sun X, Li GG, Hu QD, Fu QH, et al: Hypoxia-induced
epithelial-to-mesenchymal transition in hepatocellular carcinoma
induces an immunosuppressive tumor microenvironment to promote
metastasis. Cancer Res. 76:818–830. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nywening TM, Wang-Gillam A, Sanford DE,
Belt BA, Panni RZ, Cusworth BM, Toriola AT, Nieman RK, Worley LA,
Yano M, et al: Targeting tumour-associated macrophages with CCR2
inhibition in combination with FOLFIRINOX in patients with
borderline resectable and locally advanced pancreatic cancer: A
single-centre, open-label, dose-finding, non-randomised, phase 1b
trial. Lancet Oncol. 17:651–662. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Flecken T and Sarobe P: Tim-3 expression
in tumour-associated macrophages: A new player in HCC progression.
Gut. 64:1502–1503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan W, Liu X, Ma H, Zhang H, Song X, Gao
L, Liang X and Ma C: Tim-3 fosters HCC development by enhancing
TGF-β-mediated alternative activation of macrophages. Gut.
64:1593–1604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou W, Ke SQ, Huang Z, Flavahan W, Fang
X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, et al: Periostin
secreted by glioblastoma stem cells recruits M2 tumour-associated
macrophages and promotes malignant growth. Nat Cell Biol.
17:170–182. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heusinkveld M and van der Burg SH:
Identification and manipulation of tumor associated macrophages in
human cancers. J Transl Med. 9:2162011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lapierre M, Bonnet S, Bascoul-Mollevi C,
Ait-Arsa I, Jalaguier S, Del Rio M, Plateroti M, Roepman P, Ychou
M, Pannequin J, et al: RIP140 increases APC expression and
controls intestinal homeostasis and tumorigenesis. J Clin Invest.
124:1899–1913. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ho PC, Tsui YC, Feng X, Greaves DR and Wei
LN: NF-κB-mediated degradation of the coactivator RIP140 regulates
inflammatory responses and contributes to endotoxin tolerance. Nat
Immunol. 13:379–386. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nautiyal J, Christian M and Parker MG:
Distinct functions for RIP140 in development, inflammation, and
metabolism. Trends Endocrinol Metab. 24:451–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu PS, Lin YW, Burton FH and Wei LN:
M1-M2 balancing act in white adipose tissue browning - a new role
for RIP140. Adipocyte. 4:146–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin YW, Lee B, Liu PS and Wei LN:
Receptor-interacting protein 140 orchestrates the dynamics of
macrophage m1/m2 polarization. J Innate Immun. 8:97–107. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moreli JB, Santos JH, Lorenzon-Ojea AR,
Corrêa-Silva S, Fortunato RS, Rocha CR, Rudge MV, Damasceno DC,
Bevilacqua E and Calderon IM: Hyperglycemia differentially affects
maternal and fetal DNA integrity and DNA damage response. Int J
Biol Sci. 12:466–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng X, Krogh KA, Wu CY, Lin YW, Tsai HC,
Thayer SA and Wei LN: Receptor-interacting protein 140 attenuates
endoplasmic reticulum stress in neurons and protects against cell
death. Nat Commun. 5:4487–4495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu X, Zhou C, Li R, Liang Z, Zhai W, Zhao
L and Zhang S: Critical role for the long non-coding RNA AFAP1-AS1
in the proliferation and metastasis of hepatocellular carcinoma.
Tumour Biol. 37:9699–9707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mancino A and Lawrence T: Nuclear
factor-kappaB and tumor-associated macrophages. Clin Cancer Res.
16:784–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang CP, Su YC, Lee PH and Lei HY:
Targeting NFKB by autophagy to polarize hepatoma-associated
macrophage differentiation. Autophagy. 9:619–621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wan S, Zhao E, Kryczek I, Vatan L,
Sadovskaya A, Ludema G, Simeone DM, Zou W and Welling TH:
Tumor-associated macrophages produce interleukin 6 and signal via
STAT3 to promote expansion of human hepatocellular carcinoma stem
cells. Gastroenterology. 147:1393–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hefetz-Sela S, Stein I, Klieger Y, Porat
R, Sade-Feldman M, Zreik F, Nagler A, Pappo O, Quagliata L, Dazert
E, et al: Acquisition of an immunosuppressive protumorigenic
macrophage phenotype depending on c-Jun phosphorylation. Proc Natl
Acad Sci USA. 111:17582–17587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lalani AI, Moore CR, Luo C, Kreider BZ,
Liu Y, Morse HC III and Xie P: Myeloid cell TRAF3 regulates immune
responses and inhibits inflammation and tumor development in mice.
J Immunol. 194:334–348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu H, Luo H, Shen Z, Hu X, Sun L and Zhu
X: Transforming growth factor-β1 in carcinogenesis, progression,
and therapy in cervical cancer. Tumour Biol. 37:7075–7083. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
David CJ, Huang YH, Chen M, Su J, Zou Y,
Bardeesy N, Iacobuzio-Donahue CA and Massagué J: TGF-β tumor
suppression through a lethal EMT. Cell. 164:1015–1030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu J, Acharya S, Sahin O, Zhang Q, Saito
Y, Yao J, Wang H, Li P, Zhang L, Lowery FJ, et al: 14-3-3ζ turns
TGF-β's function from tumor suppressor to metastasis promoter in
breast cancer by contextual changes of Smad partners from p53 to
Gli2. Cancer Cell. 27:177–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gratchev A: TGF-β signalling in tumour
associated macrophages. Immunobiology. 222:75–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu L, Zhang X, Zhang B, Shi H, Yuan X, Sun
Y, Pan Z, Qian H and Xu W: Exosomes derived from gastric cancer
cells activate NF-κB pathway in macrophages to promote cancer
progression. Tumour Biol. 37:12169–12180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karin M: NF-kappaB as a critical link
between inflammation and cancer. Cold Spring Harb Perspect Biol.
1:a0001412009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ara T and Declerck YA: Interleukin-6 in
bone metastasis and cancer progression. Eur J Cancer. 46:1223–1231.
2010. View Article : Google Scholar : PubMed/NCBI
|
